Literature DB >> 21410667

Expression of interleukin (IL)-1 family members upon stimulation with IL-17 differs in keratinocytes derived from patients with psoriasis and healthy donors.

P Muhr1, J Zeitvogel, I Heitland, T Werfel, M Wittmann.   

Abstract

BACKGROUND: A number of studies have challenged the T-cell-centred pathogenetic view of psoriasis by the finding that epithelium-expressed genes are intimately involved in the inflammatory process. Interleukin (IL)-17 is an important inflammatory mediator in skin psoriasis.
OBJECTIVE: IL-17 is known to act on keratinocytes and we were interested in its impact on the expression of pro- and anti-inflammatory IL-1 family members.
METHODS: We compared human keratinocytes derived from epidermal stem cells of hair follicles plucked from patients with psoriasis and healthy individuals using quantitative reverse transcriptase-polymerase chain reaction and enzyme-linked immunosorbent assays.
RESULTS: In the presence of IL-17, psoriasis-derived keratinocytes showed a significantly higher induction of the proinflammatory IL-1 family members IL-1F6 and IL-1F9, but not of anti-inflammatory members IL-1F5, IL-1F7 or IL-1F3 compared with keratinocytes from healthy individuals. Both basal and IL-17-induced levels of IL-1F2 and IL-1F1 were found to be significantly lower in psoriasis keratinocytes.
CONCLUSION: As keratinocytes were derived from epidermal stem cells of the hair follicles and were obtained from nonlesional sites, differences found are likely to present an intrinsic feature of psoriasis epithelium. Our data support the significance of IL-1 family members as therapeutic targets in psoriasis conditions.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists 2011.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21410667     DOI: 10.1111/j.1365-2133.2011.10302.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  23 in total

1.  The double-stranded RNA analogue polyinosinic-polycytidylic acid induces keratinocyte pyroptosis and release of IL-36γ.

Authors:  Li-Hua Lian; Katelynn A Milora; Katherine K Manupipatpong; Liselotte E Jensen
Journal:  J Invest Dermatol       Date:  2012-02-09       Impact factor: 8.551

2.  Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk.

Authors:  Luigi Tortola; Esther Rosenwald; Brian Abel; Hal Blumberg; Matthias Schäfer; Anthony J Coyle; Jean-Christoph Renauld; Sabine Werner; Jan Kisielow; Manfred Kopf
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

3.  A GRHL3-regulated repair pathway suppresses immune-mediated epidermal hyperplasia.

Authors:  William M Gordon; Michael D Zeller; Rachel H Klein; William R Swindell; Hsiang Ho; Francisco Espetia; Johann E Gudjonsson; Pierre F Baldi; Bogi Andersen
Journal:  J Clin Invest       Date:  2014-10-27       Impact factor: 14.808

Review 4.  The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses.

Authors:  Michelle A Lowes; Chris B Russell; David A Martin; Jennifer E Towne; James G Krueger
Journal:  Trends Immunol       Date:  2013-01-03       Impact factor: 16.687

5.  IL-36γ (IL-1F9) is a biomarker for psoriasis skin lesions.

Authors:  Angelo Massimiliano D'Erme; Dagmar Wilsmann-Theis; Julia Wagenpfeil; Michael Hölzel; Sandra Ferring-Schmitt; Sonja Sternberg; Miriam Wittmann; Bettina Peters; Andreas Bosio; Thomas Bieber; Joerg Wenzel
Journal:  J Invest Dermatol       Date:  2014-12-19       Impact factor: 8.551

6.  IL-36γ is secreted in microparticles and exosomes by lung macrophages in response to bacteria and bacterial components.

Authors:  Melissa A Kovach; Benjamin H Singer; Michael W Newstead; Xianying Zeng; Thomas A Moore; Eric S White; Steven L Kunkel; Marc Peters-Golden; Theodore J Standiford
Journal:  J Leukoc Biol       Date:  2016-02-10       Impact factor: 4.962

7.  IL-36γ/IL-1F9, an innate T-bet target in myeloid cells.

Authors:  Malte Bachmann; Patrick Scheiermann; Lorena Härdle; Josef Pfeilschifter; Heiko Mühl
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

Review 8.  Suppression of innate inflammation and immunity by interleukin-37.

Authors:  Charles A Dinarello; Claudia Nold-Petry; Marcel Nold; Mayumi Fujita; Suzhao Li; Soohyun Kim; Philip Bufler
Journal:  Eur J Immunol       Date:  2016-05       Impact factor: 5.532

9.  IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin.

Authors:  Alexander M Foster; Jaymie Baliwag; Cynthia S Chen; Andrew M Guzman; Stefan W Stoll; Johann E Gudjonsson; Nicole L Ward; Andrew Johnston
Journal:  J Immunol       Date:  2014-05-14       Impact factor: 5.422

10.  IL-36 Cytokines Promote Inflammation in the Lungs of Long-Term Smokers.

Authors:  Melissa A Kovach; Karlhans Che; Bettina Brundin; Anders Andersson; Helga Asgeirsdottir; Médea Padra; Sara K Lindén; Ingemar Qvarfordt; Michael W Newstead; Theodore J Standiford; Anders Lindén
Journal:  Am J Respir Cell Mol Biol       Date:  2021-02       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.